Jazz Pharmaceuticals Nears Deal to Buy Celator for About $1.5 Billion

Jazz Pharmaceuticals is nearing a deal to buy Celator Pharmaceuticals for about $1.5 billion, a huge premium for a company with a promising leukemia drug but no revenue.

from WSJ.com: US Business http://ift.tt/27ZKiYC
via IFTTT